🔎 Trials Near Me

Domov › Crohnova bolezen › Florida › Orlando

Klinične študije za Crohnova bolezen v Orlando, FL

17 študij za Crohnova bolezen išče udeležence na lokacijah v Orlando in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Vključevanje udeležencevFaza 3
  • AdventHealth Orlando ( Site 5131), Orlando
  • Endoscopic Research Inc ( Site 5061), Orlando
Starost 16–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Vključevanje udeležencevFaza 2
  • Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
  • Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Vključevanje udeležencevFaza 4
  • Endoscopic Research, Inc., Orlando
  • Orlando Health-Orlando Regional Medical Center, Orlando
  • Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi stran
Starost 18–80 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Vključevanje udeležencevFaza 2
  • Endoscopic Research, Inc. /ID# 267211, Orlando
  • Novum Research /ID# 278128, Clermont · 24 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2
  • AdventHealth (Florida Hospital) Medical Group, Orlando
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • AdventHealth Orlando-Site Number: 8400070, Orlando
  • Orlando Health, Inc.-Site Number: 8400084, Orlando
  • Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi stran
  • in še 1
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
  • Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi stran
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184944

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
Starost 2–17 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05995353

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2
  • Endoscopic Research Inc, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi stran
Starost 18–85 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Vključevanje udeležencevFaza 4
  • Endoscopic Research Inc, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi stran
Starost 18–70 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Vključevanje udeležencev
  • Advent Health, Orlando
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Vključevanje udeležencevOpazovalna študija
  • AdventHealth, Orlando
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07237516

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Vključevanje udeležencevFaza 4
  • Digestive & Liver Center of Florida, Orlando
Starost 18 in več · Vsi spoli · Posodobljeno 16. jul. 2026 · NCT06997965

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2
  • Orlando Health, Inc., Orlando
Starost 18–75 · Vsi spoli · Posodobljeno 27. apr. 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Vključevanje udeležencevFaza 2
  • Investigational Site Number: 8400007, Orlando
  • Investigational Site Number: 8400017, Kissimmee · 16 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Vključevanje udeležencevFaza 2
  • Mirador Therapeutics Selected Site, Orlando
Starost 18–80 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT07113522

Študije za Crohnova bolezen v drugih mestih

Druge študije v Orlando

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.